Mutations in the PLA2G6 gene have variable phenotypic outcomes, so these different clinical groups have recently been collectively referred to as PLA2G6-associated neurodegeneration (PLAN) (Kurian et al., 2008). The gene discussed is PLA2G6; the disease is neurodegenerative disease.